Steroidal glycosides for treating hypercholesterolemia
US5629295A · kind A · utility
10Cited by
11References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 1994 |
| Grant date | May 13, 1997 |
| Priority date | — |
| Expiry date | Dec 20, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The application discloses steroidal glycoside compounds, especially spirostanyl glycosides, which have a glycosyl group O-linked to the C-3 hydroxy radical of the steroid and where the moieties at the C-10 and C-11 positions of the steroid are the same or different and are selected from the group consisiting of methylene, hydroxy and carbonyl. These steroid glycosides are useful as hypocholesterolemic agents and anti-atherosclerosis agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.